Endocrine Abstracts

Aim

To study complications in the early postoperative period in patients with DM 2 subjected to ACB

Material and methods: 60 patients (prospectively) with CHF were examinedafter endovascular revascularizationin the period of 2021 at the Center of Surgery named after acad. V.V. Vakhidov. All observed patients were divided into 2 groups: 1 gr. – 35 patients with DM2 with CHF and undergoing ACB, 2 gr. – 25 patients with CHF without DM2 who underwent ACBThe control group consisted of 20 patients with type 2 diabetes without CHF. To characterize the examined patients were used: general clinical, biochemical and instrumental examinations.

Research methods: General clinical, biochemical (bilirubin, direct, indirect, lipid spectrum, ALT, AST, coagulogram, blood sugar, glycated hemoglobin, urea, creatinine, GFR, galectin-3, insulin, renin, aldosterone in the blood) and instrumental: ECG, Echo-ECG, cardiac angiography, Dopplerography of the main vessels of the heart and legs, ultrasound of internal organs, fundus.

Results: We studied the systemic risk factors of atherosclerosis, such as age, gender, diabetes, hypertension and dyslipidemia, are to varying degrees of rejection of the graft. In the early postoperative period, these characteristics remained normal. In the early proverbial period, after A?B, our observation of complications was not observed.

Conlusion: Technical factors, such as the method used to harvest the conduits, the vasodilatory protocol, the storage solution, and the anastomotic technique, also play a major role in determining graft success.